A lack of SCFA-producing bacteria, increased opportunistic pathogens and fungi and decreased biodiversity have also been identified as microbiome features of non-responding IBD patients to anti-TNF agents[137,138]. This evidence concerns the gene TNF and irritable bowel syndrome.